%0 Journal Article
%K Public Health, Environmental and Occupational Health
%K Health Policy
%K Immunology and Microbiology (miscellaneous)
%K Biochemistry, Genetics and Molecular Biology (miscellaneous)
%K Medicine (miscellaneous)
%K albendazole (ALB)
%K ivermectin (IVM)
%B Gates Open Research
%D 2022
%G eng
%I F1000 Research Ltd
%P 62
%R 10.12688/gatesopenres.13615.1
%T An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
%U https://gatesopenresearch.org/articles/6-62/v1/pdf?article_uuid=cd652588-f5f9-4cc6-afdd-bba207a6a7fc
%V 6